Age-dependent clinical, molecular, and prognostic differences in patients with AML: a retrospective study

Key Points

• Patients aged 50 and older have poorer prognoses and more complex genetic aberrations.
• This retrospective study indicates significant differences in outcome based on age in AML patients.
• Analysis of genetic profiles and clinical data shows that elderly patients face greater treatment challenges.
• The findings suggest that treatment strategies should be optimized for older AML patients to improve outcomes.